Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

March 27, 2013

Primary Completion Date

July 29, 2016

Study Completion Date

July 29, 2016

Conditions
Legionnaires' DiseaseLegionella Pneumophila Infections
Interventions
DRUG

Azithromycin IV

"The recommended dose of ZITHROMAC (azithromycin for injection) for the treatment of adult patients with community-acquired pneumonia due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for at least two days. Intravenous therapy should be followed by azithromycin by the oral route at a single, daily dose of 500 mg, administered as two 250-mg tablets to complete a 7- to 10-day course of therapy.~The recommended dose of ZITHROMAC (azithromycin for injection) for the treatment of adult patients with pelvic inflammatory disease due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for one or two days. Intravenous therapy should be followed by azithromycin by the oral route at a single, daily dose of 250 mg to complete a 7-day course of therapy."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY